Laboratory diagnosis of actinobacillus pleuropneumonia in pigs – Articles

Available tests:


Macroscopic pathology


  • It evaluates the presence of tissue lesions, which can be practically diagnostic signs of the disease.
  • Localization of the lesion: lungs.
  • Areas of necrohemorrhagic compaction in the lung, accompanied by fibrinous pleurisy (Figure 1).


Figure 1: Typical necrohemorrhagic lung lesions associated with characteristic APP infection. Source: ISU-VDPAM.

Figure 1: Typical necrohemorrhagic lung lesions associated with characteristic APP infection. Source: ISU-VDPAM.



  • Pros:

    • A presumptive diagnosis can be made after macroscopic examination of the lungs.

  • Minuses:

    • Actinobacillus suis This may result in similar but less serious injuries.
    • It does not identify the serotype.


Bacterial culture


  • Isolation of living organisms.
  • Sample types: light.
  • Pros:

    • It can be performed in any laboratory (even internal).
    • Biotype I requires NAD (usually provided by cultured colony Staphylococcus aureus).
    • Biotype II does not require NAD.
    • Relatively low cost.

  • Minuses:

    • Not always easy to grow.
    • It does not identify the serotype.
    • If pigs have been previously treated with antibiotics, this may prevent bacterial growth.


Antimicrobial sensitivity (antibiogram)


  • Test in vitro: the ability of a living organism to grow at certain concentrations of various antimicrobials.
  • Sample types: light.
  • Pros:

    • Determining the sensitivity or resistance of specific strains to conventional antimicrobials.
    • Identifying trends in antimicrobial resistance.

  • Minuses:

    • A bacterial isolate is required.
    • Tests in vitro results may vary slightly in natural conditionsor.
    • Some specific antimicrobials may not be included or may require separate dedicated testing.
    • Moderate cost.


Polymerase chain reaction (PCR) General or serotyping


  • Detects the presence of specific bacterial nucleic acid (DNA) sequences.
  • Sample types: lungs and tonsils.
  • Pros:

    • High sensitivity.
    • General

      • It targets the ApxIV toxin genes.
      • Present in all APP serotypes.

    • Serotyping

      • It targets different parts of the toxin genes ApxI, ApxII and ApxIII.
      • See Table 1 for serotyping and toxin production.

    • Moderate cost.

      • Tissue samples can often be combined to reduce cost and minimize loss of sensitivity.

  • Minuses:

    • Requires several primers specific (primers) to determine the serotype.
    • Not all strains can be typed.

      • Currently, 19 serotypes have been identified, and this number will continue to grow.

    • Not all tests are validated for the analysis of tonsil samples.


Table 1: Toxin production for each serotype.

























Toxin production
Serotype Apxi ApxII ApxIII ApxIV
1 X X X
2 X X X
3 X X X
4 X X X
5 X X X
6 X X X
7 X X
8 X X X
9 X X X
10 X X
eleven X X X
12 X X
13 X X
14 X X
fifteen X X X
16 X X X
17 X X
18 X X
19 X X


Enzyme-linked immunosorbent assay (ELISA) Antigen LPS-O


  • Detects the presence of antibodies.
  • Sample types: serum.
  • Target: LPS-O antigen.
  • Pros:

    • Assistance with serotyping may be helpful.
    • High sensitivity.

  • Minuses:

    • High degree of cross-reactivity between serotypes due to shared capsular antigen and LPS-O antigen epitopes.

      • The following serotypes cross-react because they share LPS-O antigens:

        • Cross-reaction between serotypes 1, 9 and 11.
        • Cross-reaction between serotypes 3, 6, 8, 15, 17 and 19.
        • Cross-reaction between serotypes 4, 7 and 18.

    • It does not identify a specific serotype with a single test.
    • It is very expensive and impractical to test for all serotypes.


Enzyme-linked immunosorbent assay for ApxIV antigen (ELISA)


  • Detects the presence of antibodies.
  • Sample types: serum.
  • Target: ApxIV antigen.
  • Pros:

    • High sensitivity.
    • Detects all APP serotypes.

  • Minuses:

    • It does not identify a specific serotype.
    • It does not determine the virulence of strains.


Interpretation of results:


Macroscopic pathology


  • Positive: A preliminary diagnosis is often sufficient.
  • Negative result: there are no macroscopic lung lesions.


Bacterial culture


  • Positive:

    • Biotype 1: NAD-dependent.
    • Biotype 2: NAD-independent.

  • Negative: Negative or an animal that may have been previously treated with antibiotics.


Antimicrobial sensitivity (antibiogram)


  • Susceptible: Possibly a good choice for treatment if the antimicrobial can reach the target tissue.
  • Resistance: a different antimicrobial agent must be selected.
  • MIC: If MIC (minimum inhibitory concentration) is performed, it is necessary to ensure that the selected antimicrobial agent achieves the specified MIC value in the target organ.


PCR


  • Positive:

    • The organism is present.
    • It can reveal the presence of various genes that help in serotyping.

  • Negative:

    • Negative result or infection too old.
    • The animal may have been previously treated with antibiotics.
    • Not all strains can be serotyped (untyped).


ELISA for LPS-O antigen


  • Positive: helps determine the serotype or identify a group of serotypes.
  • Negative: Negative, the infection is too old or the animal may have been previously treated with antibiotics.


ELISA for ApxIV antigen


  • Positive: the organism is present.
  • Negative: Negative, the infection is too old or the animal may have been previously treated with antibiotics.


Scenarios:


Fattening pigs with sudden death or (acute) respiratory disease


  • Necropsy of 1-3 recently deceased pigs or euthanasia of coughing pigs. Macroscopically evaluate the lungs for areas of necrohemorrhagic consolidation accompanied by fibrinous pleurisy.
  • Submit affected lungs for bacterial culture and general PCR test for APP and, if positive, perform PCR for serotyping.


Set farm status to negative


  • Select the 30 largest pigs in the feedlot and test them 2-3 times per year using the ApxIV ELISA.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button